Outside Speakers:

Sponsors:

Faegre & Benson LLP

Baker Tilly Virchow Krause

Not every company with a great growth story is ready or able to pursue the conventional underwritten public offering pathway to listing on a regulated national stock exchange. This morning briefing will explore the progressively more visible and liquid, but increasingly burdensome, range of private and public trading market alternatives available to earlier stage companies, and will help companies consider what market options fit their state of development best. In addition, we'll consider trends in capital raising for these high growth private and smaller public companies that address the needs of today's dynamic capital markets.

Topics include:

• TSX Venture Exchange and AIM--regulated stock exchange alternatives for earlier stage companies
• OTC and Pink Sheet market alternatives available to non-SEC reporting companies and smaller reporting companies
• What does it take to move up to the NYSE, NASDAQ, NYSE Amex, Toronto Stock Exchange or London Stock Exchange; is it worth the cost and regulatory burden?
• Getting public through reverse mergers or Form 10 shells
• Current state of the equity capital markets
• Capital raising trends in the public and private markets, including registered direct offerings, confidentially marketed public offerings (CMPOs), PIPEs and bought deals.
• Corporate governance, financial reporting and other consequences of trading market and capital raising alternatives.

Alternative Public Market Strategies for High-Growth Companies (Run time: 1:06:30)

This panel will explore alternative pathways to a public market for earlier stage companies, whether to raise capital or for liquidity.

Raising Capital for the High-Growth Company (Run time: 00:39:36)

This panel will focus on capital raising trends in the public and private markets, including registered direct offerings, confidentially marketed public offerings, PIPEs and agented private placements.